HOME >> BIOLOGY >> NEWS
'Plants for the future': A European vision for plant biotechnology towards 2025

Today, the "Plants for the Future" European Technology Platform on plant genomics and biotechnology, launches a new era for plant biotechnology in Europe.

This long term vision for 2025 has been created by leading representatives from research (such as EPSO, the European Plant Science Organisation), the food and biotech industry (such as EuropaBio, CIAA, ESA), the farming community (such as COPA/COGECA) and consumer organisations (BEUC). The vision document has been presented to European Commissioner Busquin.

"Our society faces tremendous challenges in the coming decades. There will be an increased demand for healthier, higher quality and more diverse food. The need for animal feed will grow. Agricultural production needs to become more environmentally friendly: maintaining productivity while reducing inputs including water, pesticides, fertilisers, energy. The issue of economical sustainability will necessitate the development of novel biomaterials, bioenergy and renewable resources. Agriculture will also face consequences of climatic changes causing drought and spread of diseases to new areas of Europe and beyond. It is imperative that we enable developing countries to achieve self-sufficiency and become more competitive and, together with North America, to contribute to meeting the growing global food demands," says Marc Zabeau, chair of EPSO.

These immense challenges can be met by prioritizing basic and applied research goals that are tailored to the needs of European society and the agriculture and the food industries. The expertise and capabilities of European plant scientists also need to be effectively harnessed to generate a more profound understanding of plant biology. Together this new set of capabilities and priorities will enable key characteristics such as improved quality and nutrition, sustainable production, safe co-existence, and improved yield, harvestability, processability and environmental stability to be created, Nove
'"/>

Contact: Karin Metzlaff
Karin.Metzlaff@psb.ugent.be
0032-9-331-3810
VIB, Flanders Interuniversity Institute of Biotechnology
24-Jun-2004


Page: 1 2

Related biology news :

1. European common frog found to use novel mating strategy
2. Zoonotic diseases - European scientists unite to fight diseases
3. Second call for proposals for the European Young Investigator Award
4. Common call for action on European Research Council (ERC)
5. EURYI Award given for the first time to 25 young European researchers
6. European researchers tackle mitosis
7. Key principles for the foundation of a European Research Council (ERC)
8. EC boosts European electron microscopy research
9. European Commission approves Herceptin + Taxotere as 1st-line therapy in HER2-positive breast cancer
10. Limited climate tracking in European trees despite 10,000 years of postglacial warmth
11. ESA consults European science community on candidate Earth Explorer missions

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused ... Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine ... and is expected to deliver therapeutic levels of olanzapine for a period of 3 ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
Breaking Biology Technology:
Cached News: